［7月3日］指数估值数据(A股继续上涨；月薪宝创新高，再平衡的机会来了么；红利估值表更新；指数日报更新）

Core Viewpoint - The overall market is experiencing an upward trend, with various sectors showing positive performance, particularly in technology and healthcare, while the Hong Kong stock market is showing mixed results [1][4]. Market Performance - The overall market has risen, closing at 4.9 stars, with large, mid, and small-cap stocks all experiencing similar gains [1][2]. - Growth style stocks are performing strongly, while value style stocks show slight fluctuations [3]. Sector Analysis - Technology, ChiNext, and pharmaceutical biotechnology sectors have seen significant increases [4]. - The Hong Kong stock market experienced a slight decline after a previous rise, with its dividend index continuing to increase [4]. Investment Strategies - The "Yuexinbao" investment strategy has reached a historical high, with plans to adjust the stock-bond ratio [6][7]. - The "Yuexinbao" and similar strategies benefit from declining deposit rates, leading to higher returns in 2023 compared to previous years [8]. Return Sources - Returns are derived from three main components: 1. Equity Portion: Focused on value style stocks, contributing stable returns through dividends and long-term price appreciation [9][11]. 2. Bond Portion: Emphasizes short to medium-term bonds due to current low yields in long-term bonds [12]. 3. Rebalancing: Adjusting the portfolio to maintain target allocations, which can enhance returns during market fluctuations [13][18]. Historical Performance - A rebalancing opportunity occurred in February 2024, where the "Yuexinbao" strategy saw a significant recovery, with stock assets increasing by approximately 30% from February to June [19][21]. Dividend Index Valuation - The current valuation of various dividend indices indicates some are still undervalued, but they are approaching normal valuation levels [29].